← Open Payments lookup

MICHELLE KABAKIBI: Open Payments

NPI 1154849909 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$459 in 19 payments from 11 companies in 2025. Trend: 2023 $311 · 2024 $432 · 2025 $459

Food & beverage: $459
CompanyPaymentsAmount
UCB, Inc.4$119
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$49
ABBVIE INC.2$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
ABIOMED2$41
Soleno Therapeutics, Inc.2$36
Axsome Therapeutics, Inc.1$32
GENZYME CORPORATION1$30
Neurocrine BioSciences, Inc.1$22
Novo Nordisk Inc1$22

Products named: Briviact, CAPLYTA, XIFAXAN, Nayzilam, VYKAT XR, Auvelity, CERDELGA, VRAYLAR.

Industry payments across CA — which companies pay providers there.